Measures | Treatment | TRT × Day, P-value | |
Control | Probiotics | ||
Plasma Cortisol, ng/mL |
|
| 0.815 |
Day 31 | 88.5 ± 13.5 | 57.8 ± 13.5 |
|
Day 51 | 58.6 ± 13.5 | 32.8 ± 13.5 |
|
White Blood Cell (WBC), 107/10 μL |
|
| 0.354 |
Day 31 | 1.46 ± 0.28 | 2.39 ± 0.28 |
|
Day 51 | 1.92 ± 0.28 | 2.31 ± 0.28 |
|
Neutrophils, % |
|
| 0.739 |
Day 31 | 61.5 ± 7.25 | 56.2 ± 7.25 |
|
Day 51 | 58.7 ± 7.46 | 49.9 ± 7.25 |
|
Lymphocytes, % |
|
| 0.758 |
Day 31 | 39.9 ± 5.84 | 43.2 ± 5.84 |
|
Day 51 | 42.5 ± 6.08 | 49.2 ± 5.84 |
|
Monocytes, % |
|
| 0.153 |
Day 31 | 1.72 ± 1.22 | 1.39 ± 1.22 |
|
Day 51 | 1.28 ± 1.25 | 1.05 ± 1.22 |
|
Eosinophils, % |
|
| 0.680 |
Day 31 | −0.74 ± 1.38 | −0.63 ± 1.38 |
|
Day 51 | 0.56 ± 1.41 | 1.26 ± 1.38 |
|
Neutrophil-to-Lymphocyte Ratio |
|
| 0.349 |
Day 31 | 2.01 ± 0.34 | 1.31 ± 0.34 |
|
Day 51 | 1.36 ± 0.35 | 1.13 ± 0.34 |
|
Chemotaxis-IL8, no./5 fields |
|
| 0.389 |
Day 31 | 82.4 ± 18.9 | 175.5 ± 21.8 |
|
Day 51 | 80.0 ± 21.5 | 146.5 ± 17.5 |
|
Neutrophil phagocytosis, % |
|
| 0.966 |
Day 31 | 58.8 ± 5.82 | 59.1 ± 5.64 |
|
Day 51 | 54.1 ± 6.00 | 54.1 ± 5.49 |
|
Concanavalin-A proliferation |
|
| 0.0001 |
Day 31 | 1.87 ± 0.20 | 1.97 ± 0.18 |
|
Day 51 | 0.57 ± 0.23a | 1.84 ± 0.22b |
|
Lipopolysaccharide proliferation |
|
| 0.312 |
Day 31 | 1.45 ± 0.21 | 1.71 ± 0.19 |
|
Day 51 | 1.44 ± 0.25 | 2.01 ± 0.26 |
|
Interleukin-12, pg/mL |
|
| 0.532 |
Day 31 | 69.0 ± 32.1 | 81.4 ± 31.3 |
|
Day 51 | 124.8 ± 31.3 | 162.5 ± 31.3 |
|